NCT00590525View on ClinicalTrials.gov

Inflammation as a Predictor in Cardioversion of Atrial Fibrillation

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Atrial Fibrillation
Interventions
PROCEDURE

Cardioversion

Baseline hsCRP will be drawn the morning of, prior to, cardioversion. An EKG to document the patient's rhythm will be obtained at the one-month mark

Trial Locations (1)

68131

Creighton University Medical Center, Omaha

All Listed Sponsors
lead

Creighton University

OTHER

NCT00590525 - Inflammation as a Predictor in Cardioversion of Atrial Fibrillation | Biotech Hunter | Biotech Hunter